Reumophan Vit

Quick links

Choose a section

Quick links to important sections

Advertisements

Reumophan Vit

Advertisements
Advertisements

Treatment option:

Advertisements

Overview of Reumophan Vit

Quick Facts

Property Description
Active Ingredients Ketoprofen, Chlorzoxazone, Thiamine (B1), Pyridoxine (B6)
Form Fixed-dose combination, oral solid dosage form (Tablets)
Pharmacological Class Non-Steroidal Anti-Inflammatory Drug (NSAID) / Central Muscle Relaxant / Neurotropic Vitamins
General Purpose Symptomatic relief of acute pain, inflammation, and muscle spasm
Origin Synthetic and Micronutrient Combination

What Type of Medicine is Reumophan Vit?

Reumophan Vit is a fixed-dose combination product formulated as an oral tablet. This unique multicomponent preparation is classified by its three-part pharmacological action: it integrates a Non-Steroidal Anti-Inflammatory Drug (NSAID), a Central Muscle Relaxant, and essential Neurotropic B Vitamins.

The medicine is primarily synthetic in origin, stemming from the laboratory synthesis of Ketoprofen and Chlorzoxazone, integrated with the micronutrients Thiamine (B1) and Pyridoxine (B6). The inclusion of Ketoprofen confirms its role in the NSAID class, which is utilized for its efficacy in reducing inflammation.


The Core Components: Pain Relief, Muscle Relaxation, and Nerve Support

The formulation’s primary objective is to offer synergistic relief by concurrently addressing the core symptomatic triad of acute musculoskeletal discomfort. This combination is typically used for the symptomatic management of conditions characterized by pain and muscle spasms, such as an acute lumbar strain.

The Ketoprofen component provides anti-inflammatory and analgesic effects. The Chlorzoxazone component acts as a skeletal muscle relaxant, a class of medication that works to ease involuntary muscle tightness or spasm by acting on the central nervous system. The B vitamins, Thiamine and Pyridoxine, are included to support the health and metabolic function of nerve cells, providing complementary support for the overall reduction of symptoms beyond standard NSAID/muscle relaxant pairings.

Advertisements

What side effects are possible with Reumophan Vit?

The safety profile of this fixed-dose combination medicine, which includes an NSAID and a central muscle relaxant, is established through official regulatory classifications of adverse reactions, which are grouped by the system-organ class affected and categorized by frequency.

Officially Classified Adverse Reactions

Common adverse reactions typically involve the Gastrointestinal (GI) and Nervous Systems. These effects may include dyspepsia, nausea, abdominal discomfort, headache, dizziness, and drowsiness. The frequency classifications are used to communicate which effects are most frequently reported in clinical use, while other documented effects may span the Renal, Hepatobiliary, and Immune systems.

Serious Safety Constraints

The medicine is associated with documented serious adverse reactions that are central to its regulatory profile. The NSAID component carries an increased risk of serious cardiovascular thrombotic events, such as myocardial infarction and stroke. It also carries a risk of serious GI events, including bleeding, ulceration, and perforation, which may occur without warning. Furthermore, the muscle relaxant component is associated with reports of hepatocellular toxicity, including rare but documented fatal cases of liver damage.

Exposure Patterns and Special Populations

Official labeling notes that the risk of serious cardiovascular and GI events may increase with the duration of use. Specific safety considerations are defined for certain groups: older adults are officially noted to be at a greater risk for serious NSAID-related GI events. The medicine is formally contraindicated for the treatment of pain following Coronary Artery Bypass Graft (CABG) surgery and during the third trimester of pregnancy.

Advertisements

Overdose and Emergency Response

Overdose and When to Seek Help

Official regulatory documents define the overdose profile for this combination based on the established risks of its active components, Ketoprofen (NSAID) and Chlorzoxazone (muscle relaxant). The profile highlights the potential for multisystemic toxicity and the necessity for immediate emergency action.

Overdose manifestations that have been documented include gastrointestinal distress (nausea, vomiting, diarrhea, stomach pain) and Central Nervous System (CNS) effects such as drowsiness, confusion, headache, dizziness, and muscle weakness. More severe outcomes associated with acute overdose include seizures, coma, and life-threatening internal bleeding or perforation of the stomach or intestines.

Severe Outcomes Documented in Labeling Emergency Response Mandate (Label-Derived Phrasing Only)
Potential for kidney damage and, rarely, liver injury. Call the Poison Control Helpline immediately.
Serious thrombotic events (heart attack, stroke) associated with NSAID class. Contact emergency services if the victim has collapsed, has trouble breathing, or cannot be awakened.

No specific antidote is known. Management focuses on supportive measures, including the potential use of activated charcoal, gastric lavage, and continuous monitoring of vital signs as required by regulatory guidance. Elderly patients are noted to be at a greater risk for serious gastrointestinal complications.

Advertisements

Therapeutic Uses of Reumophan Vit

Main Uses and Therapeutic Intent

Reumophan Vit is a combination medication designed to manage symptoms associated with acute musculoskeletal conditions. Its primary purpose is to address inflammatory processes and moderate-to-severe pain while supporting nerve health through the inclusion of B-complex vitamins.

Primary Indications

The medication is most frequently used to treat conditions characterized by pain, inflammation, and muscle stiffness. These include:

  • Acute Osteoarthritis: Management of painful flare-ups in the joints.
  • Ankylosing Spondylitis: Relief of discomfort and inflammation in the spine and large joints.
  • Rheumatoid Arthritis: Addressing the inflammatory symptoms and pain associated with chronic joint disease.
  • Severe Musculoskeletal Pain: Treatment for acute injuries, strains, or inflammatory disorders affecting the muscles and tendons.

Therapeutic Benefits

Reumophan Vit utilizes a multi-modal approach to symptom management by combining an anti-inflammatory agent with vitamins that play a role in neurological health.

  • Reduction of Inflammation: The medication works to decrease the production of substances in the body that cause swelling, redness, and heat in affected tissues.
  • Pain Relief: By targeting inflammatory pathways, it helps reduce the intensity of acute pain signals.
  • Neurotropic Support: The inclusion of B-complex vitamins (B1, B6, and B12) is intended to support the recovery of nerve fibers that may be affected by nearby inflammation or compression. These vitamins are essential for the maintenance of the myelin sheath and proper nerve signaling.
  • Improved Mobility: By reducing pain and muscle tension, the treatment aims to help individuals regain a better range of motion during the acute phase of an injury or condition.

Regulatory References

  1. NIH MedlinePlus overview on Chlorzoxazone
Advertisements

Eligibility and Restrictions for Use

Who Can and Cannot Use Reumophan Vit? — Official Regulatory Information

The eligibility profile for Reumophan Vit (Ketoprofen/Chlorzoxazone/B Vitamins) is strictly governed by the official contraindications and limitations of its components, particularly the NSAID, Ketoprofen. Use is generally restricted to the adult population when no contraindications are present.

Contraindications and Non-Eligibility

This medicine is contraindicated and must not be used by specific populations due to severe risk as stated in regulatory documents:

  • Patients with known hypersensitivity to Ketoprofen, Chlorzoxazone, aspirin, or other Non-Steroidal Anti-Inflammatory Drugs (NSAIDs).
  • Individuals with a history of gastrointestinal bleeding, peptic ulceration, or perforation.
  • Women who are pregnant during the last trimester (from 20-30 weeks gestation onwards).
  • Patients with severe heart failure, severe renal insufficiency, or severe hepatic insufficiency.
  • Individuals requiring treatment for peri-operative pain in the setting of Coronary Artery Bypass Graft (CABG) surgery.

Age and Physiological Restrictions

Age-Related Rules: Use in the pediatric population (children and adolescents) is not recommended as safety and efficacy have not been established. Older adults may use the medicine but require caution and often a reduced initial dosage.

Pregnancy and Lactation: The medicine is contraindicated in the third trimester. Use is not recommended during the first two trimesters or while breastfeeding due to insufficient safety data.

Advertisements

What should I know about interactions with other medicines?

Interactions with other medicines and products

This section describes documented interaction patterns derived from official regulatory prescribing information.

Contraindicated and Restricted Use

The Ketoprofen component is contraindicated for use with aspirin and other NSAIDs due to a significantly increased risk of serious gastrointestinal adverse events, including bleeding and ulceration. Use is also restricted for perioperative pain in the setting of coronary artery bypass graft (CABG) surgery.

Pharmacokinetic and Pharmacodynamic Risks

Co-administration with medicines that affect coagulation, such as oral anticoagulants, antiplatelet agents, oral corticosteroids, or SSRIs, carries a documented increased risk of serious GI bleeding. Ketoprofen also reduces the renal clearance of Lithium and Methotrexate, which may result in elevated plasma concentrations of those medicines; Methotrexate requires a mandatory 12-hour separation from Ketoprofen administration. Additionally, Ketoprofen may lead to a reduced antihypertensive effect when combined with ACE inhibitors or ARBs.

The Chlorzoxazone component is associated with additive Central Nervous System (CNS) depression when used concurrently with alcohol or other CNS depressants, which may result in increased sedation.

Other Interactions

The Pyridoxine (B6) component may decrease the efficacy of Levodopa by enhancing its breakdown. The herbal product Watercress is documented to increase the exposure of Chlorzoxazone by inhibiting its metabolism. Regulatory documents note that older adults and patients with impaired renal or liver function face greater risks from the NSAID component’s interactions.

Advertisements

Mechanism of Action

How Reumophan Vit Works

The drug’s combined effect is generated by three distinct and simultaneous mechanistic actions that modulate inflammatory mediators, central nerve activity, and foundational neuronal metabolism.


COX Enzyme Inhibition and Peripheral Pathway Dampening

This core mechanistic domain involves the non-selective inhibition of Cyclooxygenase ( COX) enzymes by Ketoprofen. This action modifies the arachidonic acid pathway by suppressing the synthesis of pro-inflammatory prostaglandins, which leads to a reduction in the chemical sensitization of peripheral pain receptors and causes a limitation in the downstream effects of excessive mediator activity.


Central Neural Reflex Modulation

This domain is governed by Chlorzoxazone's action on the central nervous system (CNS), specifically modulating polysynaptic reflex arcs within the spinal cord. By generally depressing the excitability of spinal interneurons, this mechanism effectively suppresses the involuntary signaling that sustains motor neuron hyperexcitability, which results in the modulation of signaling within the targeted motor pathways.


Metabolic Coenzyme Support for Neuronal Function

The inclusion of Thiamine ( B1) and Pyridoxine ( B6) provides a mechanism involving metabolic cofactors. These essential cofactors support the efficient operation of the neuronal energy and synthesis pathways, which are necessary for neuronal structural and transmission functionality.

Advertisements

Dosage and Administration Information

Official Administration and Discontinuation Guidelines

No official, sanctioned usage instructions for “Reumophan Vit” or its variants, such as “Reumofan Plus,” are published. Instead, official guidance consists of public advisories concerning the product’s discontinuation and risk management due to the presence of undeclared, prescription-strength drug ingredients.


Administration Scope

Field Regulatory Status
Route of administration Not sanctioned; instruction is for discontinuation.
Dosing schedule No sanctioned schedule exists.
Age-group administration rules Not applicable; consultation is required for all patients who used the product.
Special procedural conditions Consultation with a healthcare professional is required to assess risk of adrenal suppression.

Instruction Classifications (High-Level)

Field Regulatory Classification
Administration method type Not sanctioned.
Frequency pattern Not sanctioned.
Regulatory basis Public Health Advisory / Warning.
Use-context constraints Product use must be discontinued under medical supervision.

Resulting Procedural Structure (Discontinuation)

The procedural steps required by official health advisories are structured to mitigate the potential harm caused by the hidden ingredients, such as the potent corticosteroid dexamethasone, and are as follows:

  • Stop the use of the product immediately.
  • Consult a healthcare professional promptly to discuss the use of the product.
  • The healthcare professional must evaluate the patient for potential complications, including corticosteroid withdrawal syndrome and adrenal suppression.
  • Follow the healthcare professional’s prescribed plan, which may include a supervised tapering regimen to safely discontinue the undeclared corticosteroid ingredient.

This procedural structure defines the protocol for managing the risks associated with this unauthorized product, emphasizing that use must be stopped only after consultation to ensure safety.

Advertisements

Recent Clinical Evidence

Research Evidence / Overview of Studies for Reumophan Vit

Research Evidence Supporting Combination Therapy

Research exploring the fixed-dose combinations, which involve a Non-Steroidal Anti-Inflammatory Drug (NSAID), a Central Muscle Relaxant, and Neurotropic B Vitamins, was evaluated in periods of heightened symptom activity. The evidence base primarily consists of Randomized Controlled Trials (RCTs) and Systematic Reviews that gather data across multiple studies.

The research has explored short-term symptom changes in populations experiencing acute physical discomfort. These studies monitored outcomes related to systemic or functional imbalance and studies examined patient-reported outcomes describing perceived discomfort. The findings generally contribute to the broader evidence landscape by helping to contextualize how patients reported their experience during defined observation periods.


Evidence for Use in Acute Musculoskeletal Pain and Associated Spasm

This area of research specifically examines conditions characterized by functional limitations and periods of heightened symptoms, such as acute low back pain, acute lumbar strain, and painful vertebral syndromes. Studies monitored outcomes related to physical discomfort and outcomes reflecting daily functioning or activity level.

Studies explored short-term RCTs to compare the study groups of combination therapies (e.g., NSAID plus a muscle relaxant, or NSAID plus B vitamins) against an NSAID monotherapy, or against a non-active comparator. These trials measured changes in symptom intensity using standardized scales and also evaluated outcomes reflecting daily functioning using specialized questionnaires. Research examined patterns observed, where the combination of agents was monitored in the observed populations during the study period.

However, a key limitation in this area is that the research is largely indirect. Most trials focus on similar two- or three-component fixed-dose products, and data for the specific combination of all four components (Ketoprofen, Chlorzoxazone, Thiamine/B1, Pyridoxine/B6) is more limited. Furthermore, evidence quality varies across studies, and some systematic reviews noted that findings were mixed due to the inclusion of different specific active agents.


Long-Term Studies and Follow-up Duration

Research exploring short-term symptom changes for these combinations often includes limited follow-up durations. The primary efficacy data derived from trials observing responses over defined time intervals typically focuses on the immediate, acute phase. Long-term effects are not fully established, and limited information exists for long-term outcomes, such as durability of effect or patterns of recurrence.


What is Still Uncertain About the Combination

The reliance on indirect evidence is a notable limitation, meaning specific, dedicated research into the exact combination is not widely available in authoritative sources, and comparative evidence is lacking. Additionally, while systematic reviews have been conducted, they note that the high variability in methodology and component drugs across different trials leads to uncertainty about the consistency of findings. Subgroup findings are uncertain, and overall, there is a clear need for further research to better characterize long-term outcomes and the performance of the fixed-dose combination in varied patient groups.

Key Studies & References

  1. Chlorzoxazone: MedlinePlus Drug Information, NIH.
Advertisements

Frequently Asked Questions (FAQ)

Common questions about Reumophan Vit (FAQ)


Q: How quickly do official documents say Reumophan Vit is supposed to start working?

Official documentation for the main components, such as Ketoprofen, indicates that the medicine is rapidly absorbed into the body. While relief of acute discomfort is the product's primary goal, official regulatory documents for this specific combination do not specify an exact timeframe (e.g., minutes) for when patients should expect to feel the initial effects.


Q: If I miss a dose of Reumophan Vit, what is the official guidance?

General regulatory guidance for the component Ketoprofen describes that a missed dose is typically taken as soon as it is remembered. However, if it is almost time for the next scheduled dose, the missed dose is usually skipped entirely. Official information indicates that doses are typically not doubled to compensate for a missed one.


Q: Can Reumophan Vit be taken with common over-the-counter pain medications?

Official regulatory documents contraindicate using the Ketoprofen component with aspirin and other non-steroidal anti-inflammatory drugs (NSAIDs) because this combination significantly increases the risk of serious gastrointestinal problems, such as bleeding. Use with non-NSAID over-the-counter pain relievers, like acetaminophen (paracetamol), is not explicitly forbidden, but it is recommended that all medicines and supplements be discussed with a healthcare professional for potential interactions.


Q: Is it possible to become dependent on Reumophan Vit with long-term use?

Regulatory bodies do not classify the muscle relaxant component, Chlorzoxazone, or the NSAID component, Ketoprofen, as controlled substances typically associated with dependence. Official warnings focus instead on the fact that the risk of serious side effects, particularly cardiovascular and gastrointestinal events, increases with the duration of use.


Q: How does Reumophan Vit differ from similar treatments for the same condition, based on its official description?

Regulatory documents describe this product as a unique fixed-dose combination that integrates three pharmacological actions simultaneously. It combines an NSAID (Ketoprofen), a Central Muscle Relaxant (Chlorzoxazone), and Neurotropic B Vitamins (B1/B6). This comprehensive approach to addressing pain, inflammation, spasm, and nerve support is what distinguishes it from simpler treatments that only contain one or two of these component types.


Q: What does the 'Vit' part of the name Reumophan Vit signify?

The 'Vit' in the product name is an abbreviation that refers to the presence of the Neurotropic B Vitamins in the formulation, specifically Thiamine (B1) and Pyridoxine (B6). These vitamins are included to provide complementary support for the metabolic function and health of nerve cells, alongside the actions of the NSAID and muscle relaxant.


Q: Are there any known interactions between Reumophan Vit and herbal supplements?

Regulatory prescribing information specifically documents that the herbal product Watercress may potentially increase the exposure of the Chlorzoxazone component by affecting its breakdown in the body. Beyond this specific example, official sources note that potential risks for all herbal products should be discussed with a healthcare professional.


Q: What is the consistency of the evidence for Reumophan Vit?

Official reviews of the evidence base note that the findings across different studies are mixed, and the quality of the supporting evidence varies. Due to the reliance on studies of similar two- or three-component products, rather than this exact four-component drug, official documents indicate there is uncertainty about the consistency of results.


Q: What are the signs of an allergic reaction to Reumophan Vit?

Signs of a serious allergic reaction, as described in regulatory documents for the components, can include hives, redness or itching of the skin, or swelling, especially of the face, tongue, or throat. Immediate medical attention is necessary if a patient believes they are experiencing a sensitivity reaction.


Q: Is there a generic version of Reumophan Vit available?

While the fixed-dose combination product itself may not have a directly comparable generic version, the individual active components—Chlorzoxazone and Ketoprofen—are both generally available in lower-cost, generic forms according to regulatory classification data.


Q: What patient monitoring is recommended while taking Reumophan Vit?

Official information advises patient monitoring due to the potential effects of the components. Renal (kidney) function may need monitoring after beginning therapy. Additionally, because the muscle relaxant component is associated with liver risks, patients with existing hepatic issues require close medical observation, and the drug may need to be stopped if signs of liver damage appear.


Q: Are there any official warnings about taking Reumophan Vit before surgery?

Regulatory documents contain specific warnings regarding surgery. The NSAID component, Ketoprofen, is contraindicated (must not be used) for treating pain during the period surrounding Coronary Artery Bypass Graft (CABG) surgery. Regulatory warnings note that general caution is appropriate before any major surgical procedure due to the antiplatelet effects associated with NSAIDs.


Q: Why do some people experience initial stomach upset when starting Reumophan Vit?

Regulatory guidance notes that the NSAID component, Ketoprofen, is known to potentially cause stomach irritation, which can lead to common side effects like upset stomach and nausea, especially when first starting the treatment. Regulatory documents mention that taking the medicine with food, milk, or an antacid is a common strategy discussed with healthcare professionals to help lessen this initial discomfort.


Q: What information exists about Reumophan Vit and fertility?

Official information for the Ketoprofen component states that NSAID use may impair female fertility and is not recommended in women who are attempting to conceive. For women planning a pregnancy, official information indicates that avoiding the medicine may be appropriate until conception attempts are complete.


Q: How long after stopping Reumophan Vit does it remain in the system?

The time the medicine remains in the system is determined by the clearance rate of its components. Official pharmacokinetic data shows that the Ketoprofen component is rapidly metabolized in the liver. Approximately 80% of an administered dose is excreted in the urine within a 24-hour period, primarily in the form of an inactive metabolite.


Q: Is Reumophan Vit used to treat nerve pain?

The medicine is primarily indicated for the symptomatic relief of acute musculoskeletal pain and spasm. However, it contains Neurotropic B Vitamins (B1/B6) specifically included to support nerve cell function. This is consistent with clinical studies where B vitamins are often used for their potential complementary role in managing pain, including in certain nerve-related conditions.


Q: What are the official sources saying about the potential for drug abuse with Reumophan Vit?

Official regulatory sources do not list the potential for drug abuse as a primary concern for this product. The muscle relaxant component, Chlorzoxazone, and the NSAID component, Ketoprofen, are both classified by authorities as Not Controlled Medications.


Q: Why is Reumophan Vit sometimes recommended for short-term use only?

Regulatory guidance advises patients to use the lowest effective dose for the shortest duration necessary to control symptoms. This is because the chance of experiencing serious side effects, such as cardiovascular events (heart attack, stroke) and gastrointestinal bleeding, is officially documented to increase with the duration of use.

Advertisements

How should Reumophan Vit be stored and disposed of?

How to Store and Dispose of Reumophan Vit?

Regulatory labeling dictates specific conditions for storing and disposing of this medicine to ensure its integrity and public safety.

Storage and Protection

Requirement Official Instruction
Temperature & Environment Store at room temperature, away from moisture, and away from light. Do not store in the bathroom or other humid areas.
Packaging Keep the medicine in its original container, tightly sealed.
Child Safety Keep Reumophan Vit and all medications out of the sight and reach of children and pets.

Disposal Guidelines

When the product is expired or no longer needed, it must be properly discarded according to official instructions. To protect the environment, the medicine must not be flushed down a toilet or poured into a drain unless explicitly stated in a national disposal guide.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Reumophan Vit found in:

A-Z Index: